Shubham Sharma | Pharmacology | Best Researcher Award

Posted on by ScienceFather

Shubham Sharma | Pharmacology | Best Researcher Award

Dr Shubham Sharma, Pfizer, United States

Dr. Shubham Sharma is a leading computational modeler with 8+ years of expertise in theoretical materials science, physics, and chemistry. Holding a Ph.D. in Chemical & Environmental Engineering from Brown University (2021), he specializes in atomistic modeling and solid-form design, notably working at Pfizer where he leads drug de-risking efforts. His research in catalysis, electrochemistry, and crystal structure predictions has earned him over 10 Pfizer Bravo awards. Dr. Sharma’s groundbreaking work is recognized globally, including invited talks at major conferences, advancing both pharmaceutical and renewable energy applications. πŸ’»πŸ”¬πŸ’Šβš‘

Publication Profile

Google Scholar

Education

This individual holds a PhD in Chemical & Environmental Engineering from Brown University, USA (2016-2021) πŸŽ“, where they conducted research under the guidance of Andrew A. Peterson πŸ§‘β€πŸ”¬. Their academic journey began with a Bachelor of Technology (B. Tech) in Chemical Engineering from the Heritage Institute of Technology, India (2012-2016) πŸ› οΈ. With a strong foundation in chemical engineering, they have pursued advanced studies focusing on environmental solutions and sustainability 🌍. Their education showcases a dedication to addressing global environmental challenges through innovative engineering approaches and cutting-edge research πŸŒ±πŸ“˜.

Work Experience

Currently serving as a Senior Scientist in Computational Materials Science at Pfizer Inc. (July 2022 – present) πŸ§‘β€πŸ”¬, this individual leads the Solid Form Design Center (SFDC) focused on de-risking potential drug molecules through advanced statistical and quantum mechanical modeling πŸ’Š. They contributed to the success of Zavegepant (Zavzpretβ„’) and Rimegepant (Nurtecβ„’) 🌟. As a core member of the Crystal Structure Prediction team, they specialize in electronic structure theory, density functional theory, and atomistic modeling 🧬. They also collaborate with global industrial and academic partners, lead multiple research proposals, and mentor colleagues in computational science πŸ”¬πŸ’».

Selected conference presentations

Sharma has delivered numerous invited talks and presentations globally 🌍. In 2024, they presented on multi-polymorphic systems at the Crystal Form Consortium Symposium (UK) and computational strategies in pharmaceutical research at UConn (US) and IISER (India) πŸ§ͺ. Sharma also discussed electrocatalysis at the 8th Global Webinar on Materials Science & Engineering in 2023 πŸ§‘β€πŸ«. Other notable presentations include de-risking medicines at AAPS NERDG (2024) and several studies on oxygen reduction reactions and catalytic properties at AIChE, NECS, ECS, and MRS conferences 🎀. Their work spans computational modeling and applied research in materials science and electrocatalysis βš›οΈ.

Research Focus

The research focus of Sharma spans electrochemistry, catalysis, and materials science. Sharma investigates the design and stability of catalysts, particularly Pt-based and CoPt alloys, for fuel cells and oxygen reduction reactions (ORR) βš‘οΈπŸ”‹. His work includes dynamic stability, reaction barriers, and potential-controlled reactions, using advanced techniques like density functional theory (DFT) and experimental-theoretical integration. He also explores solid form derisking in pharmaceuticals πŸ’Š and carbon electrodes in redox flow batteries. Sharma’s studies contribute to cleaner energy and advanced catalytic systems πŸŒπŸ”¬, emphasizing electrochemical stability and performance improvement in energy devices.

 

Publication Top Notes

Hard-magnet L10-CoPt nanoparticles advance fuel cell catalysis

Anisotropic Strain Tuning of L10Β Ternary Nanoparticles for Oxygen Reduction

Face-centered tetragonal (FCT) Fe and Co alloys of Pt as catalysts for the oxygen reduction reaction (ORR): A DFT study

Ordered CoPt oxygen reduction catalyst with high performance and durability

Metal dissolution from first principles: Potential-dependent kinetics and charge transfer

Assessment of carbon monoxide exposure in roadside food-vending shanties using coal cookstoves in Kolkata, India

Dynamic stability of Pt-based alloys for fuel-cell catalysts calculated from atomistics

Conclusion

Dr. Shubham Sharma’s innovative research in computational modeling and materials science, alongside his leadership in both academic and industrial collaborations, makes him an exceptional candidate for the Best Researcher Award. His contributions have not only advanced pharmaceutical drug design but also impacted renewable energy research, marking him as a distinguished leader in his field.

Hua Jin | Pharmacology | Women Researcher Award

Posted on by ScienceFather

Assoc Prof Dr. Hua Jin | Pharmacology | Women Researcher Award

Assoc Prof Dr. Hua Jin, Guangdong Medical University, China

Assoc. Prof. Dr. Hua Jin is an Associate Professor at Guangdong Medical University, Dongguan, China, specializing in nanochemistry, bionanomaterials, and drug delivery systems. He holds a PhD from Jinan University, China, and completed postdoctoral fellowships at Northwestern University and the University of Illinois at Chicago. Dr. Jin has published over 50 SCI papers with an H-index of 34, and holds multiple international and Chinese patents. His research primarily focuses on nanoparticle-based therapies for lung injuries and cancer. Notable publications include works in J Tissue Eng and Biomaterials Science.

 

Publication profile

Orcid

Education

Assoc. Prof. Dr. Hua Jin earned his Ph.D. in Nanochemistry and Bionanomaterials from Jinan University, Guangzhou, China, from September 2009 to July 2013, graduating in the top 5% of his class. Prior to that, he completed his M.Eng. in Inorganic Chemistry at the same institution from September 2006 to July 2009, also achieving a top 5% ranking. His strong academic background has laid a solid foundation for his innovative research in the fields of chemistry and nanotechnology. πŸŒŸπŸ”¬βœ¨

 

Work Experience

Assoc. Prof. Dr. Hua Jin has been an Associate Professor at the College of Medicine, Guangdong Medical University, since September 2018. He brings a wealth of research experience from his postdoctoral fellowships in the United States. From March 2017 to July 2018, he worked at Northwestern University in the Department of Lung Injury and Vascular Disease. Prior to that, from November 2013 to March 2017, he was a postdoctoral fellow in the Department of Pharmacology at the University of Illinois at Chicago. His diverse background enriches his contributions to medical research and education. πŸŒŸπŸ”¬

 

Research Achievements

Assoc. Prof. Dr. Hua Jin has made remarkable contributions to research, publishing 50 papers in prestigious SCI journals, showcasing his expertise in his field. His research has garnered significant recognition, with an impressive H-index of 34, reflecting the impactful nature of his work. Dr. Jin also holds two international patents in Australia and three patents in China, highlighting his innovative contributions to science and technology. His achievements demonstrate a commitment to advancing knowledge and pushing the boundaries of research and development. πŸŒπŸ“šπŸ’‘

 

Publication Top Notes Β 

  • Intratracheal Administration of Stem Cell Membrane-Cloaked Naringin-Loaded Biomimetic Nanoparticles Promotes Resolution of Acute Lung Injury (2024) – [Cited by: 2] πŸ”¬
  • Tumor targeting and penetrating biomimetic mesoporous polydopamine nanoparticles facilitate photothermal killing and autophagy blocking for synergistic tumor ablation (2021) – [Cited by: 15] πŸ“ˆ
  • Berberine-Loaded Biomimetic Nanoparticles Attenuate Inflammation of Experimental Allergic Asthma via Enhancing IL-12 Expression (2021) – [Cited by: 10] 🌱
  • Oridonin-Loaded Nanoparticles Inhibit Breast Cancer Progression Through Regulation of ROS-Related Nrf2 Signaling Pathway (2021) – [Cited by: 8] πŸ₯‡
  • GE11 Peptide Conjugated Liposomes for EGFR-Targeted and Chemophotothermal Combined Anticancer Therapy (2021) – [Cited by: 5] πŸ’Š
  • Nasal Delivery of Hesperidin/Chitosan Nanoparticles Suppresses Cytokine Storm Syndrome in a Mouse Model of Acute Lung Injury (2021) – [Cited by: 3] 🐭
  • Peptide-Decorated Supramolecules for Subcellular Targeted Cancer Therapy: Recent Advances (2020) – [Cited by: 20] πŸ“š
  • Macrophage‐Targeted Isoniazid–Selenium Nanoparticles Promote Antimicrobial Immunity and Synergize Bactericidal Destruction of Tuberculosis Bacilli (2020) – [Cited by: 12] 🦠
  • Advances in Anti-Tumor Treatments Targeting the CD47/SIRPΞ± Axis (2020) – [Cited by: 18] 🎯
  • EGFR-targeting PLGA-PEG nanoparticles as a curcumin delivery system for breast cancer therapy (2017) – [Cited by: 6] 🌼

Divya Jain | Pharmacology Award | Women Researcher Award

Posted on by ScienceFather

Dr. Divya Jain | Pharmacology Award | Women Researcher Award

Dr. Divya Jain, Uttaranchal University, India

Dr. Divya Jain is an accomplished microbiologist, holding a Ph.D. in Microbiology from Banasthali Vidyapith, Rajasthan (2023), an M.Sc. in Microbiology from Graphic Era University, Dehradun (2018), and a B.Sc. in Biotechnology from Banasthali Vidyapith (2016). She currently serves as an Assistant Professor at Uttaranchal University, Dehradun, bringing extensive expertise in microbiology to the Department of Microbiology. Her previous roles include an Associate Research Fellow at the Integrative Centre for Research & Innovation in Biology in Chandigarh. Dr. Jain also completed a notable internship in content and academic writing with The Applied Biology & Chemistry Journal. πŸ“šπŸ”¬βœ¨

Publication profile

Orcid

Google Scholar

πŸŽ“ Education

Dr. Divya Jain holds a Ph.D. in Microbiology from Banasthali Vidyapith, Rajasthan (2023), an M.Sc. in Microbiology from Graphic Era University, Dehradun (2018), and a B.Sc. in Biotechnology from Banasthali Vidyapith (2016). She completed her high school education in PCB from S.D.R.R Public School, Shamli (2013). πŸ“˜πŸ”¬

🏒 Work Experience

Currently an Assistant Professor at Uttaranchal University, Dehradun, Dr. Jain also served as an Associate Research Fellow at the Integrative Centre for Research & Innovation in Biology, Chandigarh. πŸ“šπŸ”¬

πŸ… Certificates and Awards

Dr. Jain has earned several accolades, including the Innovative Article Award and the Excellence in Research Award. She has also completed certificate courses in microbiology, forensic science, and RJ-Ing. πŸ†πŸ“œ

 

Research Focus πŸ”¬πŸŒ

Dr. Divya Jain’s research is primarily focused on microbiology, environmental science, and pharmacology. Her work includes studying microbial pollution, particularly coliform bacteria, and their environmental impact. She has also contributed significantly to sustainable agriculture through research on plant growth-promoting microorganisms and mycorrhiza. Dr. Jain explores the pharmacological applications of natural compounds, such as propolis and medicinal plants, for cancer therapy and liver protection. Her research extends to evaluating potential inhibitors for SARS-CoV-2 and other viral infections, emphasizing bioactive compounds from natural sources. Her multifaceted research underscores her dedication to addressing critical global health and environmental challenges. 🌱🧬πŸ§ͺ

 

Publication Top Notes

  • “Microbial pollution of water with special reference to coliform bacteria and their nexus with environment” 🌊🦠 (110 citations, 2021)
    S Some, R Mondal, D Mitra, D Jain, D Verma, S Das
    Energy Nexus 1, 100008
  • “Role of mycorrhiza and its associated bacteria on plant growth promotion and nutrient management in sustainable agriculture” πŸŒ±πŸ”¬ (90 citations, 2020)
    D Mitra, N Uniyal, P Panneerselvam, A Senapati, AN Ganeshamurthy
    International Journal of Life Sciences and Applied Sciences 1 (1), 1-1
  • “Propolis: An update on its chemistry and pharmacological applications” πŸ―βš—οΈ (73 citations, 2022)
    R Hossain, C Quispe, RA Khan, ASM Saikat, P Ray, D Ongalbek, …
    Chinese medicine 17 (1), 100
  • “Tobacco Smoking and Liver Cancer Risk: Potential Avenues for Carcinogenesis” πŸš¬πŸ”¬ (53 citations, 2021)
    D Jain, P Chaudhary, N Varshney, KS Bin Razzak, D Verma, …
    Journal of Oncology 2021 (1), 5905357
  • “Potential inhibitors of SARS-CoV-2 (COVID 19) proteases PLpro and Mpro/3CLpro: molecular docking and simulation studies of three pertinent medicinal plant natural components” 🧬🌿 (44 citations, 2021)
    D Verma, D Mitra, M Paul, P Chaudhary, A Kamboj, H Thatoi, P Janmeda, …
    Current Research in Pharmacology and Drug Discovery 2, 100038
  • “Biosynthesis of secondary metabolites based on the regulation of microRNAs” 🧬πŸ§ͺ (33 citations, 2022)
    R Hossain, C Quispe, ASM Saikat, D Jain, A Habib, P Janmeda, MT Islam, …
    BioMed Research International 2022 (1), 9349897
  • “Hepatoprotective activity of medicinal plants: A mini review” πŸŒΏπŸ›‘οΈ (29 citations, 2020)
    D Jain, P Chaudhary, A Kotnala, R Hossain, K Bisht, MN Hossain
    Journal of Medicinal Plants Studies 8 (5), 183-188
  • “Quercetin and/or Ascorbic Acid Modulatory Effect on Phenobarbital-Induced Sleeping Mice Possibly through GABAA and GABAB Receptor Interaction Pathway” πŸ’€πŸŠ (25 citations, 2021)
    R Hossain, K Al-Khafaji, RA Khan, C Sarkar, MS Islam, D Dey, D Jain, …
    Pharmaceuticals 14 (8), 721
  • “Anticancer effects of acteoside: Mechanistic insights and therapeutic status” πŸ§¬πŸŽ—οΈ (22 citations, 2022)
    RA Khan, R Hossain, P Roy, D Jain, ASM Saikat, APR Shuvo, M Akram, …
    European Journal of Pharmacology 916, 174699
  • “Carcinogenic effects of N-nitroso compounds in environment” 🚫🦠 (22 citations, 2020)
    D Jain, P Chaudhary, N Varshney, P Janmeda
    Environment Conservation Journal 21 (3), 25-41